Maternal And Fetal Outcomes in Pregnant Women With Liver Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06594237

Enrollment

195

Registered

2024-09-19

Start date

2023-07-01

Completion date

2024-08-31

Last updated

2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fulminant Hepatic Failure

Brief summary

Liver disease complications during pregnancy can impact maternal and neonatal health, though not many studies are on view to investigate maternal and fetal outcomes in Pakistani pregnant women. So, this study was aimed to determine the maternal and fetal outcomes among pregnant females with liver disease.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Pregnant females with liver disease * With gestational age \> 24 weeks * Any parity or gravidity status

Exclusion criteria

* Pregnant females with renal disease or any kind of malignancy

Design outcomes

Primary

Measure	Time frame	Description
Maternal or Fetal survival or mortality.	24 hours	Fetal and maternal outcomes in terms of survival or death were noted.

Countries

Pakistan

Outcome results